The total return over the past 12 months is -49.96% vs. +16.94% for the S&P 500. So far it's up -20.16% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (49.96%) | (8.35%) | (24.47%) | N/A | N/A | N/A |
| Total Return CAGR | (49.96%) | (8.35%) | (24.47%) | N/A | N/A | N/A |
| Revenue CAGR | (100.00%) | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | (394.72%) | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | (396.00%) | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | (279.11%) | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | (279.11%) | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Black Diamond Therapeutics, Inc. (BDTX)
| Year | Start price | End price | BDTX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $2.43 | $1.94 | (20.16%) | +14.51% | (34.67%) |
| 2025 | $2.14 | $2.43 | +13.55% | +17.72% | (4.17%) |
| 2024 | $2.81 | $2.14 | (23.84%) | +24.89% | (48.73%) |
| 2023 | $1.80 | $2.81 | +56.11% | +26.19% | +29.92% |
| 2022 | $5.33 | $1.80 | (66.23%) | (18.17%) | (48.06%) |
| 2021 | $32.05 | $5.33 | (83.37%) | +28.74% | (112.11%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
